Search Results - "Beilman, G.J."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Proposed Thresholds for Pancreatic Tissue Volume for Safe Intraportal Islet Autotransplantation After Total Pancreatectomy by Wilhelm, J. J., Bellin, M. D., Dunn, T. B., Balamurugan, A. N., Pruett, T. L., Radosevich, D. M., Chinnakotla, S., Schwarzenberg, S. J., Freeman, M. L., Hering, B. J., Sutherland, D. E. R., Beilman, G. J.

    Published in American journal of transplantation (01-12-2013)
    “…The simple question of how much tissue volume (TV) is really safe to infuse in total pancreatectomy–islet autotransplantation (TP–IAT) for chronic pancreatitis…”
    Get full text
    Journal Article
  2. 2

    Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation by Forlenza, G.P., Nathan, B.M., Moran, A.M., Dunn, T.B., Beilman, G.J., Pruett, T.L., Bellin, M.D.

    Published in American journal of transplantation (01-02-2016)
    “…Total pancreatectomy with islet autotransplantation (TPIAT) may relieve the pain of chronic pancreatitis while avoiding postsurgical diabetes. Minimizing…”
    Get full text
    Journal Article
  3. 3

    Human Islet Isolation for Autologous Transplantation: Comparison of Yield and Function Using SERVA/Nordmark Versus Roche Enzymes by Anazawa, T., Balamurugan, A. N., Bellin, M., Zhang, H. J., Matsumoto, S., Yonekawa, Y., Tanaka, T., Loganathan, G., Papas, K. K., Beilman, G. J., Hering, B. J., Sutherland, D. E. R.

    Published in American journal of transplantation (01-10-2009)
    “…Islet autotransplantation (IAT) is used to preserve as much insulin‐secretory capacity as possible in patients undergoing total pancreatectomy for painful…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Metabolic testing partially predicts islet yield in patients undergoing total pancreatectomy and islet autotransplantation by Lundberg, R, Beilman, G.J, Dunn, Ty B, Pruett, T.L, Freeman, M.L, Ptacek, P, Berry, K.L, Wilhelm, J.J, Balamurugan, A.N, Bellin, M.D

    “…Methods: 44 non-diabetic patients (38 female) with CP (mean BMI 25.4 ± 5.9 kg/m2 and mean age 37.9 ±11.4) undergoing TP-IAT between 2010 and 2012 completed IV…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation by Kizilgul, M., Wilhelm, J.J., Dunn, T.B., Beilman, G.J., Pruett, T.L., Chinnakotla, S., Amin, K., Hering, B.J., Bellin, M.D.

    Published in Diabetes & metabolism (01-06-2019)
    “…Islet autotransplantation (IAT) is considered a ‘non-immune’ model of islet transplant, with no risk for autoimmune-mediated beta cell loss, but we have…”
    Get full text
    Journal Article
  12. 12

    Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo‐Controlled Study by Bellin, M. D., Beilman, G. J., Dunn, T. B., Pruett, T. L., Sutherland, D. E. R., Chinnakotla, S., Hodges, J. S., Lane, A., Ptacek, P., Berry, K. L., Hering, B. J., Moran, A.

    Published in American journal of transplantation (01-02-2017)
    “…Insulin independence after total pancreatectomy and islet autotransplant (TPIAT) for chronic pancreatitis is limited by a high rate of postprocedure beta cell…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16